Short answer

Designers can leverage bioprinting to create complex, multi-cellular 3D structures that mimic native tissue architecture, facilitating more accurate biological simulations and therapeutic applications.

Field: Modelling
Source: Biofabrication (2015)
Method: Experimental (Bioprinting and Cell Culture)
Evidence: Strong effect

Valve-based bioprinting technology can successfully encapsulate and maintain the viability and pluripotency of human stem cells, enabling their subsequent directed differentiation into functional cell types within a 3D structure. This modelling research insight is drawn from a 2015 study published in Biofabrication. Using Experimental (bioprinting and cell culture), researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers can leverage bioprinting to create complex, multi-cellular 3D structures that mimic native tissue architecture, facilitating more accurate biological simulations and therapeutic applications.

Study

ModellingHigh ImpactStrong effect

Bioprinting maintains stem cell viability and differentiation potential in 3D tissue models

Biofabrication · 2015

Key Findings

01Valve-based bioprinting successfully maintained the viability and pluripotency of hPSCs.
02Printed hPSCs could be directed to differentiate into hepatocyte-like cells (HLCs) expressing hepatic markers and secreting albumin.
033D printed HLC constructs showed peak albumin secretion at day 21 of differentiation.

Application

Design takeaway

How to apply

When designing models for drug efficacy testing or disease simulation, consider using bioprinting to create 3D cellular constructs that better replicate in vivo conditions.

Project actions

01When designing a biological model, consider the spatial arrangement of cells and how this impacts function.
02Explore how different printing technologies might affect cell viability and behavior.

Method & Evidence

AimTo investigate the feasibility of bioprinting human pluripotent stem cells (hPSCs) using a valve-based system and assess their viability, pluripotency, and directed differentiation into hepatocyte-like cells (HLCs) within a 3D matrix.

MethodExperimental (Bioprinting and Cell Culture)

ProcedureHuman induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) were encapsulated within an alginate hydrogel matrix using a valve-based bioprinting system. The printed cells were then cultured and assessed for viability, pluripotency markers, and directed differentiation into hepatocyte-like cells (HLCs), evaluating for hepatic markers, albumin secretion, and cell morphology. Differentiation protocols were applied to the 3D printed constructs.

ContextBiofabrication of 3D tissue models for regenerative medicine and drug development.

Variables

IV["Bioprinting process (printed vs. non-printed cells)","Cell type (hESC vs. hiPSC)","Differentiation protocol"]

DV["Cell viability","Pluripotency markers","Hepatic markers (e.g., nuclear factor 4 alpha)","Albumin secretion","Cell morphology"]

CV["Biomaterial composition (alginate hydrogel)","Culture conditions (temperature, media)","Incubation time"]

Strengths & Limitations

Strengths

+First investigation into bioprinting hPSCs with this specific valve-based method.
+Demonstrated viability and differentiation potential of printed stem cells.
+Validation of hepatic markers and function.

Limitations

The complexity of replicating the full in vivo environment in a lab setting, the cost and accessibility of bioprinting equipment, and the need for specialized cell culture expertise.

Reliability & validity

Reliability could be improved by repeating the printing and differentiation experiments multiple times with consistent parameters. Validity is supported by the use of established markers for pluripotency and hepatic differentiation, and by comparing printed cells to non-printed controls.

Think critically

How might the choice of biomaterial (e.g., alginate) and printing parameters (e.g., pressure, nozzle size) influence the differentiation potential and long-term viability of the printed stem cells?

Design Principles

"Cellular viability and functional differentiation can be preserved within engineered 3D microenvironments created through precise bioprinting techniques."

This research demonstrates a novel method for creating complex biological constructs, moving beyond traditional 2D cell cultures. The ability to precisely arrange cells in 3D opens up possibilities for more accurate disease modelling, drug testing, and the eventual development of engineered tissues and organs.

What This Means for Your Design

Scientists can use a special 3D printer to print living stem cells into specific shapes, and these cells still act like normal stem cells and can even turn into liver cells. This is important for making better models of diseases and for future medical treatments.

How to use in your project

1.Reference this study when discussing the use of 3D printing for creating biological models or when exploring advanced manufacturing techniques for cell-based applications.

Add to My Project

Quick Cite

Paragraph starter

The bioprinting of human pluripotent stem cells (hPSCs) using a valve-based system has been shown to maintain cell viability and pluripotency, allowing for subsequent directed differentiation into functional hepatocyte-like cells within a 3D construct (Faulkner-Jones et al., 2015). This demonstrates the potential of advanced manufacturing techniques to create complex biological models for research and therapeutic development.

Source

Biofabrication

Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D

journal · 2015

View source

Questions About This Research

What does the research say about bioprinting maintains stem cell viability and differentiation potential in 3d tissue models?: Designers can leverage bioprinting to create complex, multi-cellular 3D structures that mimic native tissue architecture, facilitating more accurate biological simulations and therapeutic applications. Evidence: Biofabrication (2015).
Why does "Bioprinting maintains stem cell viability and differentiation potential in 3D tissue models" matter for design?: This research demonstrates a novel method for creating complex biological constructs, moving beyond traditional 2D cell cultures. The ability to precisely arrange cells in 3D opens up possibilities for more accurate disease modelling, drug testing, and the eventual development of engineered tissues and organs.
How can designers apply this research?: Designers can leverage bioprinting to create complex, multi-cellular 3D structures that mimic native tissue architecture, facilitating more accurate biological simulations and therapeutic applications.
What were the main findings?: Valve-based bioprinting successfully maintained the viability and pluripotency of hPSCs.. Printed hPSCs could be directed to differentiate into hepatocyte-like cells (HLCs) expressing hepatic markers and secreting albumin.. 3D printed HLC constructs showed peak albumin secretion at day 21 of differentiation.
What research method was used?: Experimental (Bioprinting and Cell Culture).
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2015 journal from Biofabrication.
What should I do differently in my next project?: When designing models for drug efficacy testing or disease simulation, consider using bioprinting to create 3D cellular constructs that better replicate in vivo conditions.
What are the limitations?: The study focused on specific cell types (hPSCs, hESCs, HLCs) and a particular bioprinting method (valve-based). Long-term functionality and integration of printed tissues in vivo were not assessed.